Coronavirus Vaccine Work Faces Funding Gap of Almost $2 Billion
This article is for subscribers only.
The push to develop vaccines against the new coronavirus will be in jeopardy without almost $2 billion in additional funding, according to the group coordinating the global effort.
The Coalition for Epidemic Preparedness Innovations needs $375 million by the end of March to support trials and efforts to expand global manufacturing capacity, according to a statement Friday, and another $1.55 billion will be required by 2021. The Oslo-based group said it’s already committed $100 million of its own funds to get experimental vaccines ready for early human trials.